Brief: AcuCort: Gets Extended Patent Protection In The US
16/04/2018 08:04
April 16 (Reuters) - ACUCORT AB ACUC.TE :
* ACUCORT'S PATENT IS GRANTED WITH 1,349 DAYS EXTENDED
PATENT
PROTECTION IN THE US
* USPTO HAS EXTENDED PATENT TERM AND PATENT PROTECTION HAS
THUS
BEEN EXTENDED UNTIL JANUARY 1, 2028
Source text for Eikon: ID:nWkr6ctXXS
Further company coverage: ACUC.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA